The growing adoption of GLP-1 therapies is impacting food choices, with consumers increasingly focusing on nutrient-dense, high-protein, and high-fiber options to support their health. Industry experts note that smaller, convenient options with high nutritional quality are crucial to accommodate users who are eating less. Nutrition Insight meets with Ingredion, Fonterra, and Carbery to explore innovation opportunities for the food and nutrition industry as GLP-1s are driving demand for nutrient-dense options in smaller formats.
